Breath analysis for label-free characterisation of airways disease

Stephen J. Fowler

Source: Eur Respir J, 51 (1) 1702586; 10.1183/13993003.02586-2017
Journal Issue: January
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Stephen J. Fowler. Breath analysis for label-free characterisation of airways disease. Eur Respir J, 51 (1) 1702586; 10.1183/13993003.02586-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Feasibility of using multiplex technology for simultaneous quantification of inflammatory proteins in exhaled particles
Source: International Congress 2016 – Phenotyping asthma
Year: 2016


Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate
Source: International Congress 2019 – Basic research of airway diseases
Year: 2019



Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease
Source: Eur Respir J, 57 (1) 2002042; 10.1183/13993003.02042-2020
Year: 2021



Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011

Breath analysis in real time by mass spectrometry in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013


Detection of lung cancer by analysis of exhaled breath: from sniffing dogs to modern mass-spectrometric techniques
Source: Annual Congress 2013 –Early detection of lung cancer
Year: 2013


Breath analysis for discriminating and phenotyping COPD and asthma
Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances
Year: 2010


Sensitive automated airway-artery method to monitor progression of CF airway disease
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021



The analysis of breath air by laser spectroscopy method for diagnosis of COPD
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017

SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009

Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring
Source: Eur Respir J 2006; 28: Suppl. 50, 152s
Year: 2006

Is NMR-based metabolomic analysis of exhaled breath condensate accurate?
Source: Eur Respir J 2011; 37: 468
Year: 2011


Reproducibility data of breath analysis through a gas sensors array and comparison to spirometry in COPD patients
Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Year: 2011

Explorative breath analysis study for the detection and classification of PAH
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Differential measurement of exhaled breath temperature allows characterization of the spread of inflammation in airways diseases
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Unbiased cluster analysis of severe asthma based on metabolomics by the U-BIOPRED electronic nose platform
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013


External validation of exhaled breath molecular profiling in identifying COPD and asthma
Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances
Year: 2010


Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study.
Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Year: 2017

Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019